These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38200398)

  • 1. Health-related quality of life across disease stages in patients with amyotrophic lateral sclerosis: results from a real-world survey.
    Stenson K; Fecteau TE; O'Callaghan L; Bryden P; Mellor J; Wright J; Earl L; Thomas O; Iqbal H; Barlow S; Parvanta S
    J Neurol; 2024 May; 271(5):2390-2404. PubMed ID: 38200398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
    Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey.
    Stenson K; O'Callaghan L; Mellor J; Wright J; Gibson G; Earl L; Barlow S; Fournier CN
    J Neurol Sci; 2023 Sep; 452():120764. PubMed ID: 37639764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden and preparedness of care partners of people living with amyotrophic lateral sclerosis at home in Korea: A care partner survey.
    Lee SY; Yoo SH; Cho B; Kim KH; Jang MS; Shin J; Hwang I; Choi SJ; Sung JJ; Kim MS
    Muscle Nerve; 2024 Sep; 70(3):306-315. PubMed ID: 38760965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
    He R; Zheng M; Lian L; Yao X
    Cells; 2021 May; 10(5):. PubMed ID: 34067647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health utility decreases with increasing clinical stage in amyotrophic lateral sclerosis.
    Jones AR; Jivraj N; Balendra R; Murphy C; Kelly J; Thornhill M; Young C; Shaw PJ; Leigh PN; Turner MR; Steen IN; McCrone P; Al-Chalabi A
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Jun; 15(3-4):285-91. PubMed ID: 24641613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany.
    Schönfelder E; Osmanovic A; Müschen LH; Petri S; Schreiber-Katz O
    Orphanet J Rare Dis; 2020 Jun; 15(1):149. PubMed ID: 32532288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' self-perceived burden, caregivers' burden and quality of life for amyotrophic lateral sclerosis patients: a cross-sectional study.
    Geng D; Ou R; Miao X; Zhao L; Wei Q; Chen X; Liang Y; Shang H; Yang R
    J Clin Nurs; 2017 Oct; 26(19-20):3188-3199. PubMed ID: 27874996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data.
    Prell T; Gaur N; Steinbach R; Witte OW; Grosskreutz J
    Health Qual Life Outcomes; 2020 May; 18(1):117. PubMed ID: 32357946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
    Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Chiò A; Andrews JA; Genge A; Jackson CE; Lechtzin N; Miller TM; Shefner JM
    Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):304-310. PubMed ID: 36503310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
    Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nation-Wide, Multi-Center Study on the Quality of Life of ALS Patients in Germany.
    Peseschkian T; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Büchner B; Weiland U; Schönfelder E; Heinrich F; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O
    Brain Sci; 2021 Mar; 11(3):. PubMed ID: 33799476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
    Al-Chalabi A; Chiò A; Merrill C; Oster G; Bornheimer R; Agnese W; Apple S
    J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):165-171. PubMed ID: 33109706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-world assessment of the impact of "OFF" episodes on health-related quality of life among patients with Parkinson's disease in the United States.
    Thach A; Jones E; Pappert E; Pike J; Wright J; Gillespie A
    BMC Neurol; 2021 Jan; 21(1):46. PubMed ID: 33516182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' health-related quality of life and utilities associated with different stages of amyotrophic lateral sclerosis.
    Kiebert GM; Green C; Murphy C; Mitchell JD; O'Brien M; Burrell A; Leigh PN
    J Neurol Sci; 2001 Oct; 191(1-2):87-93. PubMed ID: 11676997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health Utilities and Costs for Motor Neurone Disease.
    Moore A; Young CA; Hughes DA
    Value Health; 2019 Nov; 22(11):1257-1265. PubMed ID: 31708062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of quality of life changes in amyotrophic lateral sclerosis patients.
    Shamshiri H; Fatehi F; Abolfazli R; Harirchian MH; Sedighi B; Zamani B; Roudbari A; Razazian N; Khamseh F; Nafissi S
    J Neurol Sci; 2016 Sep; 368():35-40. PubMed ID: 27538598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.
    Luna J; Couratier P; Lahmadi S; Lautrette G; Fontana A; Tortelli R; Logroscino G; Preux PM; Copetti M; Benoit M
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):478-485. PubMed ID: 33829938
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Fatigue on Health-Related Quality of Life and Work Productivity in Psoriatic Arthritis: Findings From a Real-World Survey.
    Gossec L; Walsh JA; Michaud K; Holdsworth E; Peterson S; Meakin S; Yang F; Booth N; Chakravarty SD; Piercy J; Dennis N; Ogdie A
    J Rheumatol; 2022 Nov; 49(11):1221-1228. PubMed ID: 35840154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time from amyotrophic lateral sclerosis symptom onset to key disease milestones: analysis of data from a multinational cross-sectional survey.
    Gebrehiwet P; Brekke J; Rudnicki SA; Mellor J; Wright J; Earl L; Ball N; Iqbal H; Thomas O; Castellano G
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):345-357. PubMed ID: 38156828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.